Clinical Trials Browser

Interventional × Glioblastoma × Naltrexone × Clear all

NCT01303835 2015-07-17

Low Dose Naltrexone for Glioma Patients

Phase 2 Completed

110 enrolled 9 charts

Glioblastoma, Glioma